Thomas Strüngmann (born 1950) founded generic drug maker Hexal AG in 1986.
In 2005, he and his brother Andreas sold Hexal for $6.7B.
They earned $8B on their stake in BioNTech SE, the German company developing the Pfizer vaccine.
They own approximately 50% of the company as well as significant ownership in 4SC and Immatics.
The brothers operate out of a family office, Athos Service.
He is no. 123rd richest person in the world with a net worth of USD 15.6B
In 2005, he and his brother Andreas sold Hexal for $6.7B.
They earned $8B on their stake in BioNTech SE, the German company developing the Pfizer vaccine.
They own approximately 50% of the company as well as significant ownership in 4SC and Immatics.
The brothers operate out of a family office, Athos Service.
He is no. 123rd richest person in the world with a net worth of USD 15.6B